Huntsman Cancer Institute (HCI Group) received a recommendation from a proprietary system using the Zacks Growth Style Score and carried a top Zacks Rank.
3 reports, 2 independent
Updated Aug 29
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Huntsman Cancer Institute (HCI Group) received a recommendation from a proprietary system using the Zacks Growth Style Score and carried a top Zacks Rank.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Huntsman Cancer Institute
cancer research facility and hospital located on the campus of the University of Utah
Nothing else this week.
Coverage
Newest first; wire copies grouped- Zacks3 Reasons Why Growth Investors Shouldn't Overlook HCI Group (HCI) Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attenti
- StockStoryHCI Q2 Deep Dive: Technology and Underwriting Discipline Drive Profitable Growth, Exzeo IPO in Focus Insurance and technology company HCI Group (NYSE:HCI) reported Q2 CY2025 results exceeding the mar
- ZacksHCI Group, Inc. (HCI) is Attracting Investor Attention: Here is What You Should Know HCI Group (HCI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to rev